Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability
Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfat...
Gespeichert in:
Veröffentlicht in: | Pharmacological research 2012-06, Vol.65 (6), p.592-602 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 602 |
---|---|
container_issue | 6 |
container_start_page | 592 |
container_title | Pharmacological research |
container_volume | 65 |
creator | Saha, S. Hollands, W. Needs, P.W. Ostertag, L.M. de Roos, B. Duthie, G.G. Kroon, P.A. |
description | Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS. |
doi_str_mv | 10.1016/j.phrs.2012.02.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837310464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661812000230</els_id><sourcerecordid>1010496084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</originalsourceid><addsrcrecordid>eNqFkUFu1TAQhi1ERUvhAiyQl-0iD9tJnASxQRXQSpW6KWvLsSc8Pzl2ajut3g1Y92gcgZPgkIJYoFayZFvz_f-M5kfoDSUbSih_t9tM2xA3jFC2IfmQ-hk6oqTjBaUtf768q7LgnLaH6GWMO0JIV1HyAh0yVjYlr9sj9ON8HqXDV0Wc7SATaDxCkr23JkHEfsAnP7_fnxYwGZWramsclu43tN3b4j_FAHjyPuA49zEFubgM-av8OEJQRtqMZOXaTkaI7_HFONnFwXi3wjHN2mSh8k5BcHmoO5O2-GaWLplhb9w3_G_P3nh5K42Vvclj71-hg0HaCK8f7mP09fOn67Pz4vLqy8XZx8tClW2XCqBcDaqpgVbAJZGKgQKgrK55Q_XAm5ZpQnvSUlXpBpgsa0lV16uqrhjTTXmMTlbfKfibGWISo4kKrJUO_BwFbfOScwS8eholmes4aReUragKPsYAg5iCGfPOMrRwXOzEErtYYhckH1Jn0dsH_7kfQf-V_Mk5Ax9WAPJCbg0EEZWBvF1tAqgktDeP-f8CgVbF-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1010496084</pqid></control><display><type>article</type><title>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Saha, S. ; Hollands, W. ; Needs, P.W. ; Ostertag, L.M. ; de Roos, B. ; Duthie, G.G. ; Kroon, P.A.</creator><creatorcontrib>Saha, S. ; Hollands, W. ; Needs, P.W. ; Ostertag, L.M. ; de Roos, B. ; Duthie, G.G. ; Kroon, P.A.</creatorcontrib><description>Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2012.02.005</identifier><identifier>PMID: 22373658</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Absorption ; Administration, Oral ; Arylsulfatases - metabolism ; Biological Availability ; Biotransformation ; Catechin - administration & dosage ; Catechin - analogs & derivatives ; Catechin - blood ; Catechin - metabolism ; Catechin - urine ; Chromatography, Liquid ; Cross-Over Studies ; Dietary bioactives ; England ; Female ; Flavonoids ; Glucuronidase - metabolism ; Human metabolism ; Humans ; Hydrogen-Ion Concentration ; Hydrolysis ; Male ; Methylation ; Phase-2 enzymes ; Phenolics ; Polyphenols ; Reproducibility of Results ; Substrate Specificity ; Sulfuric Acid Esters - administration & dosage ; Sulfuric Acid Esters - blood ; Sulfuric Acid Esters - metabolism ; Sulfuric Acid Esters - urine ; Tandem Mass Spectrometry ; Time Factors</subject><ispartof>Pharmacological research, 2012-06, Vol.65 (6), p.592-602</ispartof><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</citedby><cites>FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.phrs.2012.02.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22373658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saha, S.</creatorcontrib><creatorcontrib>Hollands, W.</creatorcontrib><creatorcontrib>Needs, P.W.</creatorcontrib><creatorcontrib>Ostertag, L.M.</creatorcontrib><creatorcontrib>de Roos, B.</creatorcontrib><creatorcontrib>Duthie, G.G.</creatorcontrib><creatorcontrib>Kroon, P.A.</creatorcontrib><title>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.</description><subject>Absorption</subject><subject>Administration, Oral</subject><subject>Arylsulfatases - metabolism</subject><subject>Biological Availability</subject><subject>Biotransformation</subject><subject>Catechin - administration & dosage</subject><subject>Catechin - analogs & derivatives</subject><subject>Catechin - blood</subject><subject>Catechin - metabolism</subject><subject>Catechin - urine</subject><subject>Chromatography, Liquid</subject><subject>Cross-Over Studies</subject><subject>Dietary bioactives</subject><subject>England</subject><subject>Female</subject><subject>Flavonoids</subject><subject>Glucuronidase - metabolism</subject><subject>Human metabolism</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hydrolysis</subject><subject>Male</subject><subject>Methylation</subject><subject>Phase-2 enzymes</subject><subject>Phenolics</subject><subject>Polyphenols</subject><subject>Reproducibility of Results</subject><subject>Substrate Specificity</subject><subject>Sulfuric Acid Esters - administration & dosage</subject><subject>Sulfuric Acid Esters - blood</subject><subject>Sulfuric Acid Esters - metabolism</subject><subject>Sulfuric Acid Esters - urine</subject><subject>Tandem Mass Spectrometry</subject><subject>Time Factors</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFu1TAQhi1ERUvhAiyQl-0iD9tJnASxQRXQSpW6KWvLsSc8Pzl2ajut3g1Y92gcgZPgkIJYoFayZFvz_f-M5kfoDSUbSih_t9tM2xA3jFC2IfmQ-hk6oqTjBaUtf768q7LgnLaH6GWMO0JIV1HyAh0yVjYlr9sj9ON8HqXDV0Wc7SATaDxCkr23JkHEfsAnP7_fnxYwGZWramsclu43tN3b4j_FAHjyPuA49zEFubgM-av8OEJQRtqMZOXaTkaI7_HFONnFwXi3wjHN2mSh8k5BcHmoO5O2-GaWLplhb9w3_G_P3nh5K42Vvclj71-hg0HaCK8f7mP09fOn67Pz4vLqy8XZx8tClW2XCqBcDaqpgVbAJZGKgQKgrK55Q_XAm5ZpQnvSUlXpBpgsa0lV16uqrhjTTXmMTlbfKfibGWISo4kKrJUO_BwFbfOScwS8eholmes4aReUragKPsYAg5iCGfPOMrRwXOzEErtYYhckH1Jn0dsH_7kfQf-V_Mk5Ax9WAPJCbg0EEZWBvF1tAqgktDeP-f8CgVbF-A</recordid><startdate>201206</startdate><enddate>201206</enddate><creator>Saha, S.</creator><creator>Hollands, W.</creator><creator>Needs, P.W.</creator><creator>Ostertag, L.M.</creator><creator>de Roos, B.</creator><creator>Duthie, G.G.</creator><creator>Kroon, P.A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201206</creationdate><title>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</title><author>Saha, S. ; Hollands, W. ; Needs, P.W. ; Ostertag, L.M. ; de Roos, B. ; Duthie, G.G. ; Kroon, P.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-e16cfc75e14e6a0ac2ecee1255671df6782d01b081c4d7e2a35a1c9bc45422d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Absorption</topic><topic>Administration, Oral</topic><topic>Arylsulfatases - metabolism</topic><topic>Biological Availability</topic><topic>Biotransformation</topic><topic>Catechin - administration & dosage</topic><topic>Catechin - analogs & derivatives</topic><topic>Catechin - blood</topic><topic>Catechin - metabolism</topic><topic>Catechin - urine</topic><topic>Chromatography, Liquid</topic><topic>Cross-Over Studies</topic><topic>Dietary bioactives</topic><topic>England</topic><topic>Female</topic><topic>Flavonoids</topic><topic>Glucuronidase - metabolism</topic><topic>Human metabolism</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hydrolysis</topic><topic>Male</topic><topic>Methylation</topic><topic>Phase-2 enzymes</topic><topic>Phenolics</topic><topic>Polyphenols</topic><topic>Reproducibility of Results</topic><topic>Substrate Specificity</topic><topic>Sulfuric Acid Esters - administration & dosage</topic><topic>Sulfuric Acid Esters - blood</topic><topic>Sulfuric Acid Esters - metabolism</topic><topic>Sulfuric Acid Esters - urine</topic><topic>Tandem Mass Spectrometry</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saha, S.</creatorcontrib><creatorcontrib>Hollands, W.</creatorcontrib><creatorcontrib>Needs, P.W.</creatorcontrib><creatorcontrib>Ostertag, L.M.</creatorcontrib><creatorcontrib>de Roos, B.</creatorcontrib><creatorcontrib>Duthie, G.G.</creatorcontrib><creatorcontrib>Kroon, P.A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saha, S.</au><au>Hollands, W.</au><au>Needs, P.W.</au><au>Ostertag, L.M.</au><au>de Roos, B.</au><au>Duthie, G.G.</au><au>Kroon, P.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2012-06</date><risdate>2012</risdate><volume>65</volume><issue>6</issue><spage>592</spage><epage>602</epage><pages>592-602</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>Epicatechin is a widely consumed dietary flavonoid and there is substantial evidence that it contributes to the health benefits reported for flavanol-rich cocoa products including dark chocolate. Numerous reports have described the appearance of epicatechin and epicatechin phase-2 conjugates (sulfates and glucuronides of epicatechin and methylepicatechin) in blood and urine samples of subjects following ingestion of epicatechin. The most widely reported method of quantifying total epicatechin in plasma and urine samples involves hydrolysis with a mixture of β-glucuronidase and sulfatase to convert the conjugates to epicatechin aglycone which is subsequently quantified. We observed a lack of hydrolysis of epicatechin sulfates and methylepicatechin sulfates using commercial sulfatases and investigated this further. Samples of urine or plasma from subjects who had consumed epicatechin were subjected to enzyme hydrolysis and then analysed using LC–MS/MS, or analysed without enzyme hydrolysis. Attempts to increase the extent of hydrolysis of epicatechin conjugates were made by increasing the amount of enzyme, hydrolysis pH and length of incubations, and using alternative sources of enzyme. The standard hydrolysis conditions failed to hydrolyse the majority of epicatechin sulfates and methylepicatechin sulfates. Even when the quantity of enzyme and incubation period was increased, the pH optimised, or alternative sources of sulfatases were used, epicatechin monosulfates and methylepicatechin monosulfates remained as major peaks in the chromatograms of the samples. An assessment of literature data strongly suggested that the majority of reports where enzyme hydrolysis was used had significantly underestimated epicatechin bioavailability in humans. Methods for quantifying epicatechin concentrations in blood and urine need to take account of the lack of hydrolysis of (methyl)epicatechin-sulfates, for example by quantifying these directly using LC–MS/MS.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>22373658</pmid><doi>10.1016/j.phrs.2012.02.005</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-6618 |
ispartof | Pharmacological research, 2012-06, Vol.65 (6), p.592-602 |
issn | 1043-6618 1096-1186 |
language | eng |
recordid | cdi_proquest_miscellaneous_1837310464 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
subjects | Absorption Administration, Oral Arylsulfatases - metabolism Biological Availability Biotransformation Catechin - administration & dosage Catechin - analogs & derivatives Catechin - blood Catechin - metabolism Catechin - urine Chromatography, Liquid Cross-Over Studies Dietary bioactives England Female Flavonoids Glucuronidase - metabolism Human metabolism Humans Hydrogen-Ion Concentration Hydrolysis Male Methylation Phase-2 enzymes Phenolics Polyphenols Reproducibility of Results Substrate Specificity Sulfuric Acid Esters - administration & dosage Sulfuric Acid Esters - blood Sulfuric Acid Esters - metabolism Sulfuric Acid Esters - urine Tandem Mass Spectrometry Time Factors |
title | Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin bioavailability |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A49%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20O-sulfated%20metabolites%20of%20(%E2%88%92)-epicatechin%20and%20methyl-(%E2%88%92)-epicatechin%20are%20poor%20substrates%20for%20commercial%20aryl-sulfatases:%20Implications%20for%20studies%20concerned%20with%20quantifying%20epicatechin%20bioavailability&rft.jtitle=Pharmacological%20research&rft.au=Saha,%20S.&rft.date=2012-06&rft.volume=65&rft.issue=6&rft.spage=592&rft.epage=602&rft.pages=592-602&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2012.02.005&rft_dat=%3Cproquest_cross%3E1010496084%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1010496084&rft_id=info:pmid/22373658&rft_els_id=S1043661812000230&rfr_iscdi=true |